Breeding for stress tolerance
Genomic selection and marker-assisted breeding speed the development of varieties tolerant to drought, heat, salinity and pests, tested in multi-site trials under the conditions farmers face.
The Global Centre for Risk and Innovation (GCRI)
Biotechnology platforms in food and agriculture include marker-assisted and genomic breeding, gene editing, biological inputs, diagnostics for plant and animal disease, and fermentation-based food production. They widen the options for resilience and raise questions of biosafety, access and governance that regulators must resolve.
Agricultural biotechnology is the use of biological techniques to breed crops and animals, develop biological inputs, diagnose pests and diseases and produce food by fermentation. It widens options for resilience and raises biosafety, access and governance questions that national regulators decide under rules such as the Cartagena Protocol.
The working screen behind this method: its structure, terms and states. Names are placeholders and values illustrative.
Food · Biotechnology in food and… · Run R-3210
capacity and oversight only
| Project P-790 | Institutional committee | Level 1 | Q3 | Conditions |
| Project P-211 | Institutional committee | Level 2 | Q1 | Conditions |
| Project P-961 | Institutional committee | Level 1 | Q2 | Approved |
| Project P-399 | Institutional committee | Level 2 | Q1 | Approved |
Biotechnology platforms apply biological systems to produce medicines, diagnostics, materials and agricultural products. They expand response capacity for health threats while introducing dual-use and biosafety concerns. In food and agriculture, trade, resources and supply chains and climate and hazards, biotechnology capacity shapes how quickly countermeasures can be produced in a crisis. Its supply chains and dual-use potential are part of biosecurity planning. The canonical description is on the STEM Commons.
Genomic selection and marker-assisted breeding speed the development of varieties tolerant to drought, heat, salinity and pests, tested in multi-site trials under the conditions farmers face.
Molecular and field diagnostics identify plant pathogens and animal diseases quickly, so surveillance can confirm an outbreak and response can begin before it spreads.
Case-by-case assessment of food, feed and environmental safety follows the Cartagena Protocol and Codex principles, with data gaps and post-release monitoring stated.
Each term as this page uses it. Where a standard-setting body defines the term, the wording follows that body.
| Term | Definition |
|---|---|
| Marker-assisted selection | Breeding that uses DNA markers linked to desired traits to select plants or animals more quickly and accurately. |
| Gene editing | Techniques such as CRISPR that make targeted changes to an organism's DNA; regulators differ on how they classify the products. |
| Living modified organism | An organism with a novel combination of genetic material obtained through modern biotechnology, as the Cartagena Protocol defines it. |
Plains, deltas and basins, the corridors that carry food to ports, and how far each division sits from one, shown for Brazil as an example geography for this subject.
Data from the source register feeds the methods; calibration and an independent test gate the estimate and its limits; the decision stays with the competent authority.
Fig. 01Nodes carry their type, metrics and state; connectors show what feeds what; the gates are the validation steps; the timeline is one application. Design of the method's use, not a record of a run.
Datasets and records used by biotechnology platforms on this platform, with the role each plays and the label its values carry. Sources are listed in the source register.
| Data | Role | Label |
|---|---|---|
| Genomic and germplasm databases | Trait discovery and breeding | OBSERVED |
| Multi-site trial data | Variety performance | OBSERVED |
| Biosafety Clearing-House records | Regulatory decisions | OFFICIAL |
| Diagnostic laboratory records | Outbreak confirmation | OBSERVED |
Products are evaluated through staged preclinical and clinical testing and manufacturing quality controls. Regulatory review and independent replication check claims.
| Check | How it is done |
|---|---|
| Independent replication | Trait and product claims are replicated across sites, seasons and laboratories |
| Regulatory review | Products are assessed by competent national authorities before release |
| Post-release monitoring | Performance and unintended effects are monitored after adoption |
Scale-up from laboratory to production often fails or takes time. Containment and oversight can lag behind technical capability.
Biotechnology and Biosecurity stewards biotechnology platforms for the Consortium and reviews how it is applied across platforms.
The current service level is R0: information and enquiries. An enquiry receives a reference and names the next step; applications, payments, compute allocations and registrations open only when their team, terms and review capacity exist.